Sandoz confirms European Commission approval of Pyzchiva ® (ustekinumab), further strengthening immunology offering

Pyzchiva® approved as one of first ustekinumab biosimilars in Europe • EC approval based on robust development program confirming match to reference medicine in terms of safety, efficacy and quality • Sandoz remains committed to accelerating access to potentially life-changing treatments and…#sandoz #basel #europeancommission #samsungbioepis #rebeccaguntern #sandozeurope #pyzchiva #europeaneconomicarea #switzerland #samsungbioepiscoltd
Source: Reuters: Health - Category: Consumer Health News Source Type: news